law: National Institute of Pharmaceutical Education and Research Act, 1998
  4. Establishment of Institute
  (1) With effect from such date as the Central
  
  Government may, by notification in the official Gazette, appoint, the National
  
  Institute of Pharmaceutical Education and Research shall be constituted as a
  
  body corporate by name aforesaid.
  (2) The Institute shall have perpetual
  
  succession and a common seal with power, subject to the provisions of this act,
  
  to acquire, hold and dispose of property and to contract, and shall, by that
  
  name, sue and be sued.
  (3) The Institute shall consist of the board
  
  of Governors having the following persons, namely:-
  (a) a Chairperson, who
  
  shall be an eminent academician, scientist or technologist or professional, to
  
  be nominated by the Visitor;
  (b) the director of
  
  the Institute, ex officio;
  (c) the Joint
  
  Secretary, incharge of Pharmaceutical Industries in the concerned Ministry or
  
  Department of the Government of India , ex officio;
  (d) the Secretary,
  
  Technical Education, Government of Punjab, Chandigarh, ex officio;
  (e) the Financial
  
  Adviser of the Ministry or Department of the Government of India dealing with
  
  the pharmaceutical industries, ex officio;
  (f) the Drug
  
  Controller General of India, Ministry of Health and Family Welfare of the
  
  Government of India, ex officio,.
  (g) the Member 
  
  Secretary, All-India Council for Technical Education, ex officio
  (h) the Director of
  
  any one of the national laboratories of the Council of Scientific and
  
  Industrial Research to be nominated by the Director General of Council of
  
  Scientific and Industrial Research, New Delhi;
  (i) the Director of
  
  either the All-India Institute of Medical Sciences, New Delhi or the
  
  Post-Graduate Institute of Medical Education and Research, Chandigarh, to be
  
  nominated by rotation by the Ministry of Health and Family Welfare of the
  
  Government of India;
  (j) the President,
  
  Indian Drugs Manufacturers' Association, ex officio;
  (k) the President,
  
  Organization of Pharmaceutical Producers of India, ex officio;
  (l) three eminent
  
  pharmaceutical experts, one of whom shall be an educationist; a research
  
  scientist and a biotechnologist, to be nominated by the Central Government;
  (m) three eminent
  
  public persons or social workers one of whom shall be either from the Scheduled
  
  Castes or the Scheduled Tribes to be nominated by the Visitor out of a panel
  
  prepared by the Central Government;
  (n) two pharmaceutical
  
  industrialists to be nominated by the Visitor out of a panel prepared by the
  
  Central Government;
  (o) three Members of
  
  Parliament, two from Lok Sabha to be nominated by the Speaker of Lok Sabha and
  
  one from Rajya Sabha to be nominated by the Chairman of Rajya Sabha.
  (4) The term of office of the Chairperson and
  
  Governors other than ex officio Governors shall be three years and they shall
  
  be entitled for such allowances as may be determined by the Central Government.
  (5) the term of office of Governor nominated
  
  to fill a casual vacancy shall continue for the remainder of the tern of the
  
  Governor in whose place he has been nominated.
  (6) The Board shall meet at least three times
  
  in a year at such place and time and observe such rules of procedure in regard
  
  to the transaction of business at its meetings as may be determined by the
  
  Board.